FIGO 2023 endometrial cancer staging: too much, too soon?W Glenn McCluggage, Tjalling Bosse, C Blake Gilks, Brooke E Howitt, Jessica N McAlpine, Marisa R Nucci, Joseph T Rabban, Naveena Singh, Karen L Talia, Carlos Parra-Herran
7 November 2023
Cardiophrenic lymph nodes in advanced ovarian cancerNuria Agusti, Giulio Bonaldo, Ryan M Kahn, Andrea Rosati, Dania Nachira, Teresa L Pan, Anisa Mburu, Gvantsa Kochiashvili, Pilar Paredes, Heng-Cheng Hsu, Jennifer Davies-Oliveira, Pedro T Ramirez
14 December 2023
Impact of adjuvant chemotherapy on the overall survival of patients with advanced-stage low-grade serous ovarian carcinoma following primary cytoreductive surgeryDimitrios Nasioudis, Xiaolei Wang, Gurdial Dhillon, Nawar Latif, Emily M Ko, Robert L Giuntoli II, David Gershenson, Amanda Fader, Mark Carey, Fiona Simpkins
25 October 2023
Uterine transposition for fertility and ovarian function preservation after radiotherapyReitan Ribeiro, Glauco Baiocchi, Renato Moretti-Marques, José Clemente Linhares, Caroline Nadai Costa, Rene Pareja
28 October 2023
Prophylactic anticoagulation after minimally invasive hysterectomy for endometrial cancer: a cost-effectiveness analysisSarah Bell, Taylor Orellana, Alison Garrett, Kenneth Smith, Haeyon Kim, Abigail Rosiello, Shannon Rush, Jessica Berger, Jamie Lesnock
30 October 2023
The promise of combining CDK4/6 inhibition with hormonal therapy in the first-line treatment setting for metastatic or recurrent endometrial adenocarcinomaIsabelle Ray-Coquard, Bradley J Monk, Domenica Lorusso, Haider Mahdi, Vivek Upadhyay, Regina Graul, Amreen Husain, Mansoor Raza Mirza, Brian Slomovitz
31 October 2023
Evolving treatment paradigms in metastatic or recurrent low-grade endometrial cancer: When is hormonal-based therapy the preferred option?Haider Mahdi, Isabelle Ray-Coquard, Domenica Lorusso, Mansoor Raza Mirza, Bradley J Monk, Brian Slomovitz
27 August 2023
Optimizing disease progression assessment using blinded central independent review and comparing it with investigator assessment in the PRIMA/ENGOT-ov26/GOG-3012 trial: challenges and solutionsThomas J Herzog, Shaun A Wahab, Mansoor R Mirza, Bhavana Pothuri, Ignace Vergote, Whitney S Graybill, Izabela A Malinowska, Whitney York, Jean A Hurteau, Divya Gupta, Antonio González-Martin, Bradley J Monk
6 November 2023
Cost impact analysis of enhanced recovery after minimally invasive gynecologic oncology surgeryCristina Mitric, Sarah Daisy Kosa, Soyoun Rachel Kim, Gregg Nelson, Stephane Laframboise, Geneviève Bouchard-Fortier
31 July 2023
Impact of gynecological cancers on health-related quality of life: historical context, measurement instruments, and current knowledgeBlanca Gil-Ibanez, Jennifer Davies-Oliveira, Gregorio Lopez, Berta Díaz-Feijoo, Alvaro Tejerizo-Garcia, Jalid Sehouli
11 September 2023